← All stocks

Dyne Therapeutics, Inc.

DYN Mostly scheduled
CIK 0001818794 #1391 in the set updated 17 Sep 2026
Bought (12 mo)
$274.84K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$168.62M
$168.57M on a plan · $0.00 straight out of an exercise
Sold at will
$48.11K
1 of 122 sales
Net
−$168.34M
+$226.73K against sales at will

By person

12 insiders · 129 transactions
11.2×

John G. Cox holds 11.2 times base salary in stock. $8.11M of shares against $721.00K in salary for 2025.

Salary from the company's own proxy. The shares are what John G. Cox last reported holding, valued at $18.88, the price Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Rhodes Jason P
Director
$129.10M (79) scheduled
−$129.10M
428,946
0.2297%
$8.10M
−91.4%
Kersten Dirk
Director
$38.57M (19) scheduled
−$38.57M
3,586,796
1.92%
$67.72M
−42.1%
Cox John
CEO & President
$443.69K (6) scheduled
−$443.69K
429,507
0.2300%
$8.11M
+457.8%
Posner Brian S
Director
$274.84K (7)
+$274.84K
24,500
0.0131%
$462.56K
+188.2%
Kerr Douglas
Chief Medical Officer
$233.11K (7) scheduled
−$233.11K
162,564
0.0871%
$3.07M
+242.2%
Lucera Erick
Chief Financial Officer
$228.68K (4) scheduled
−$228.68K
119,766
0.0641%
$2.26M
Friedl-Naderer Johanna
Chief Commercial Officer
$43.38K (7) scheduled
−$43.38K
152,897
0.0819%
$2.89M
+161.8%
Beskrovnaya Oxana
Chief Scientific Officer
195,840
0.1049%
$3.70M
+37.2%
HIGH SUSANNA GATTI
Chief Operating Officer
131,636
0.0705%
$2.49M
−6.4%
Scalzo Richard William
SVP, Head of Finance & Admin.
122,330
0.0655%
$2.31M
+22.4%
Lubner David Charles
Director
0
0.0000%
$0.00
−100.0%
Incerti Carlo
Director
0
0.0000%
$0.00
Insider
Date
Role
Action
Shares
Price
Amount
Posner Brian S
8 Jun 2026
Director
Buy
2,000
$16.94
$33.88K
Posner Brian S
3 Jun 2026
Director
Buy
2,500
$17.48
$43.70K
Posner Brian S
26 May 2026
Director
Buy
2,000
$18.21
$36.42K
Posner Brian S
20 May 2026
Director
Buy
2,500
$17.12
$42.80K
Posner Brian S
30 Mar 2026
Director
Buy
2,000
$17.08
$34.16K
Posner Brian S
11 Mar 2026
Director
Buy
2,000
$19.35
$38.70K
Posner Brian S
6 Mar 2026
Director
Buy
3,000
$15.06
$45.18K

What was left out

Form 4 filings counted 59
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 121
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 443,625
History held since 18 Sep 2020